Document:

Non-Qualified Stock Option Agreement

 Exhibit 10.33 
 BG MEDICINE, INC. 
 NON-QUALIFIED STOCK OPTION AGREEMENT

 AGREEMENT made as of the 9th day of January 2012, by and between BG Medicine, Inc. (the “Company”), a
Delaware corporation, and Eric Bouvier (the “Participant”). 
 WHEREAS, the Company desires to grant to the
Participant an option to purchase shares of its common stock, $0.001 par value per share (the “Shares”) as an inducement material to the Participant’s entering into employment as President and Chief Executive Officer of the Company in
accordance with the terms of an employment agreement with the Company dated October 29, 2011 and effective as of January 9, 2012 (the “Employment Agreement”); 

WHEREAS, the Company and the Participant each intend that the option granted herein shall be a non-qualified stock option (the
“Option”). 
 NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and
valuable consideration, the parties hereto agree as follows: 
 1. GRANT OF OPTION. 

The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of 725,675 Shares, on the
terms and conditions and subject to all the limitations set forth herein, under United States securities and tax laws. Except as expressly provided in this Agreement, no issuance by the Company of shares of stock of any class, or securities
convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number of the Shares. Except as expressly provided in this Agreement, no adjustments shall be made for dividends paid
in cash or in property (including without limitation, securities) of the Company. 
 2. EXERCISE PRICE. 

The exercise price of the Shares covered by the Option shall be $5.17 per share, subject to adjustment, as provided in Section 9 of
this Agreement, in the event of a stock split, reverse stock split or other events affecting the holders of Shares after the date hereof (the “Exercise Price”). Payment shall be made in accordance with Section 5(b) of this Agreement.

 3. EXERCISABILITY OF OPTION. 
 Subject to the terms and conditions set forth in this Agreement, the Option granted hereby shall become vested and exercisable as follows: 

 

			
	 On the first anniversary of the date of this Agreement
	  	25% of the unvested Shares
		
	 On the last day of each successive three month period following the first anniversary of the date of this
Agreement
	  	An additional 6.25% of the unvested Shares until the fourth anniversary of the date of this Agreement.

 provided that the Participant is then providing services as an employee, director or consultant of the
Company or of an Affiliate. The number of Shares vesting on each date shall be rounded down to the nearest whole number, while the number of Shares vesting on the final date shall be the remaining unvested balance of the Shares. 

The foregoing rights are cumulative and are subject to the other terms and conditions of this Agreement. 

In addition, if the Participant involuntarily ceases to be an employee of the Company or of an Affiliate within twelve (12) months
following the consummation of a Change of Control for any reason other than death, Disability, or termination of the Participant by the Company for Cause, then conditioned upon the Participant’s execution of a separation agreement as set forth
in Section 4(b) of the Employment Agreement and continued compliance through the exercise date with the Participant’s obligations set forth in the Confidentiality Agreement (as defined in the Employment Agreement) a portion of this Option
to the extent then outstanding immediately prior to such involuntary termination shall be accelerated such that the number of unvested Shares which would have vested over the next twelve months if the Participant had continued to be an employee of
the Company or of an Affiliate shall be deemed vested and exercisable as of the date of execution of such separation agreement. 

4. TERM OF OPTION. 
 This Option shall terminate ten years from the date of this Agreement (the “Option Expiration Date”), but shall be subject to earlier termination as provided herein. 

If the Participant ceases to be an employee, director or consultant of the Company or of an Affiliate for any reason other than the death
or Disability of the Participant, or termination of the Participant for Cause (the “Termination Date”), the Option to the extent vested and exercisable pursuant to Section 3 hereof, and not previously terminated in accordance with
this Agreement, may be exercised within three months after the Termination Date, or on or prior to the Option Expiration Date, whichever is earlier, but may not be exercised thereafter except as set forth below. In such event, the unvested portion
of the Option as of the Termination Date that is not subject to accelerated vesting pursuant to Section 3 hereof shall never be exercisable and shall expire and be cancelled on the Termination Date. 

Notwithstanding the foregoing, in the event of the Participant’s Disability or death within three months after the Termination Date,
the Participant or the Participant’s Survivors may exercise the Option to the extent vested and exercisable pursuant to Section 3 hereof, within one year after the Termination Date, but in no event after the Option Expiration Date.

 In the event the Participant’s service is terminated by the Company or an Affiliate for Cause, the Participant’s
right to exercise any unexercised portion of this Option even if vested shall cease immediately as of the time the Participant is notified his or her service is terminated for Cause, and this Option shall thereupon terminate. Notwithstanding
anything 

  
 2 

 
herein to the contrary, if subsequent to the Participant’s termination, but prior to the exercise of the Option, the Administrator determines that, either prior or subsequent to the
Participant’s termination, the Participant engaged in conduct which would constitute Cause, then the Participant shall immediately cease to have any right to exercise the Option and this Option shall thereupon terminate. 

In the event of the Disability of the Participant, the Option shall be exercisable within one year after the Participant’s
termination of service due to Disability or, if earlier, on or prior to the Option Expiration Date. In such event, the Option shall be exercisable: 
  

	 	(a)	to the extent that the Option has become exercisable but has not been exercised as of the date of the Participant’s termination of service due to Disability; and

  

	 	(b)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of the Participant’s termination of service
due to Disability of any additional vesting rights that would have accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued in the current vesting period prior to the date
of the Participant’s termination of service due to Disability. 

 In the event of the death of the
Participant while an employee, director or consultant of the Company or of an Affiliate, the Option shall be exercisable by the Participant’s Survivors within one year after the date of death of the Participant or, if earlier, on or prior to
the Option Expiration Date. In such event, the Option shall be exercisable: 
  

	 	(x)	to the extent that the Option has become exercisable but has not been exercised as of the date of death; and 

 

	 	(y)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of death of any additional vesting rights that
would have accrued on the next vesting date had the Participant not died. The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant’s date of death. 

5. METHOD OF EXERCISING OPTION. 
 (a) Subject to the terms and conditions of this Agreement, the Option may be exercised by written notice to the Company or its designee, in substantially the form of Exhibit A attached hereto
(or in such other form acceptable to the Company, which may include electronic notice). Such notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option (which
signature may be provided electronically in a form acceptable to the Company). Payment of the Exercise Price for such Shares shall be made in accordance with Section 5(b) of this Agreement. The Company shall deliver such Shares as soon as
practicable after the notice shall be received, provided, however, that the Company may delay issuance of such Shares until completion of any action or obtaining of any consent, which the Company deems necessary under any applicable law

  
 3 

 
(including, without limitation, state securities or “blue sky” laws). The Shares as to which the Option shall have been so exercised shall be registered in the Company’s share
register in the name of the person so exercising the Option (or, if the Option shall be exercised by the Participant and if the Participant shall so request in the notice exercising the Option, shall be registered in the Company’s share
register in the name of the Participant and another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the person exercising the Option. In the event the Option shall be exercised,
pursuant to Section 4 hereof, by any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Shares that shall be purchased upon the exercise of the Option
as provided herein shall be fully paid and nonassessable. 
 (b) Payment of the Exercise Price for the Shares as to which such
Option is being exercised shall be made (a) in United States dollars in cash or by check, or (b) at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six months (if required to avoid negative
accounting treatment) having a fair market value equal as of the date of the exercise to the aggregate cash Exercise Price for the number of Shares as to which the Option is being exercised, or (c) at the discretion of the Administrator, by
having the Company retain from the Shares otherwise issuable upon exercise of the Option, a number of Shares having a fair market value equal as of the date of exercise to the aggregate Exercise Price for the number of Shares as to which the Option
is being exercised, or (d) at the discretion of the Administrator, in accordance with a cashless exercise program established with a securities brokerage firm, and approved by the Administrator, or (e) at the discretion of the
Administrator, by any combination of (a), (b), (c) and (d) above, or (f) at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. 

6. PARTIAL EXERCISE. 
 Exercise of this Option to the extent above stated may be made in part at any time and from time to time within the above limits, except that no fractional share shall be issued pursuant to this Option.

 7. NON-ASSIGNABILITY. 
 The Option shall not be transferable by the Participant otherwise than by will or by the laws of descent and distribution. This Option may also be transferred pursuant to a qualified domestic relations
order as defined by the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder and the Participant, with the approval of the Administrator, may transfer the Option for no consideration to or for the benefit of the
Participant’s Immediate Family (including, without limitation, to a trust for the benefit of the Participant’s Immediate Family or to a partnership or limited liability company for one or more members of the Participant’s Immediate
Family), subject to such limits as the Administrator may establish, and the transferee shall remain subject to all the terms and conditions applicable to the Option prior to such transfer and each such transferee shall so acknowledge in writing as a
condition precedent to the effectiveness of such transfer. The term “Immediate Family” shall mean the Participant’s spouse, former spouse, parents, children, stepchildren, adoptive relationships, sisters, brothers, nieces, nephews and
grandchildren (and, for this purpose, shall 

  
 4 

 
also include the Participant). Except as provided above in this paragraph, the Option shall be exercisable, during the Participant’s lifetime, only by the Participant (or, in the event of
legal incapacity or incompetency, by the Participant’s guardian or representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or
similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 7, or the levy of any attachment or similar process upon
the Option shall be null and void. 
 8. NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE. 

The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until registration of the Shares
in the Company’s share register in the name of the Participant. Except as provided in Section 9 of this Agreement, no adjustment shall be made for dividends or similar rights for which the record date is prior to the date of such
registration. 
 9. ADJUSTMENTS. 
 Upon the occurrence of any of the following events, the Participant’s rights with respect to the Option, except to the extent previously exercised shall be adjusted as hereinafter provided:

 (a) Stock Dividends and Stock Splits. If (i) shares of Common Stock shall be subdivided or combined into a
greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii) additional shares or new or different shares or other securities of the Company or other
non-cash assets are distributed with respect to such shares of Common Stock, the number of shares of Common Stock deliverable upon the exercise of the Option shall be appropriately increased or decreased proportionately, and appropriate adjustments
shall be made including, in the Exercise Price, to reflect such events. 
 (b) Corporate Transactions. If the Company is
to be consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company’s assets other than a transaction to merely change the state of incorporation (a “Corporate
Transaction”), the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the “Successor Board”), shall, as to this Option, either (i) make appropriate provision for the
continuation of the Option by substituting on an equitable basis for the Shares then subject to the Option either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or
securities of any successor or acquiring entity; or (ii) upon written notice to the Participant, provide that the Option must be exercised (either (A) to the extent then exercisable or, (B) at the discretion of the Administrator, the
Option being made partially or fully exercisable for purposes of this Subsection), within a specified number of days of the date of such notice, at the end of which period the Option which has not been exercised shall terminate; or
(iii) terminate the Option in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock into which the

  
 5 

 
Option would have been exercisable (either (A) to the extent then exercisable or, (B) at the discretion of the Administrator, the Option being made partially or fully exercisable for
purposes of this Subsection) less the aggregate Exercise Price. For purposes of determining the payments to be made pursuant to Subclause (iii) above, in the case of a Corporate Transaction the consideration for which, in whole or in part, is
other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board of Directors. 
 (c) Recapitalization or Reorganization. In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of
another corporation are issued with respect to the outstanding shares of Common Stock, the Participant upon exercising the Option after the recapitalization or reorganization shall be entitled to receive for the price paid upon such exercise, the
number of replacement securities which would have been received if the Option had been exercised prior to such recapitalization or reorganization. 
 (d) Dissolution or Liquidation of the Company. Upon the dissolution or liquidation of the Company, the Option will terminate and become null and void; provided, however, that if the rights of the
Participant or the Participant’s Survivors have not otherwise terminated and expired, the Participant or the Participant’s Survivors will have the right immediately prior to such dissolution or liquidation to exercise the Option to the
extent that the Option is exercisable as of the date immediately prior to such dissolution or liquidation. 
 (e)
Modification of Option. Notwithstanding the foregoing, any adjustments made pursuant to Subsection (a), (b) or (c) above with respect to the Option shall be made only after the Administrator determines whether such adjustments would
cause any adverse tax consequences to the Participant, including, but not limited to, pursuant to Section 409A of the Code. If the Administrator determines that such adjustments made with respect to the Option cause adverse tax consequence, it
may refrain from making such adjustments, unless the Participant specifically agrees in writing that such adjustment be made and such writing indicates that the Participant has full knowledge of the consequences on his or her income tax treatment
with respect to the Option. 
 10. TAXES. 
 The Participant acknowledges that any income or other taxes due from him or her with respect to this Option or the Shares issuable pursuant to this Option shall be the Participant’s responsibility.
The Participant acknowledges and agrees that (i) the Participant was free to use professional advisors of his or her choice in connection with this Agreement, has received advice from his or her professional advisors in connection with this
Agreement, understands its meaning and import, and is entering into this Agreement freely and without coercion or duress; (ii) the Participant has not received and is not relying upon any advice, representations or assurances made by or on
behalf of the Company or any Affiliate or any employee of or counsel to the Company or any Affiliate regarding any tax or other effects or implications of the Option, the Shares or other matters contemplated by this Agreement and (iii) neither
the Administrator, the Company, its Affiliates, nor any of its officers or directors, shall be held liable for any applicable costs, taxes, or penalties associated with the Option if, in fact, the Internal Revenue Service were to determine that the
Option constitutes deferred compensation under Section 409A of the Code. 

  
 6 

 If this Option is exercised, the Participant agrees that the Company may withhold from the
Participant’s remuneration, if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered compensation includable in such person’s gross income. At the Company’s
discretion, the amount required to be withheld may be withheld in cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant on exercise of the Option. The Participant further agrees that, if the Company does
not withhold an amount from the Participant’s remuneration sufficient to satisfy the Company’s income tax withholding obligation, the Participant will reimburse the Company on demand, in cash, for the amount under-withheld. 

11. PURCHASE FOR INVESTMENT. 
 Unless the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered under the Securities Act of 1933, as now in force or hereafter
amended (the “1933 Act”), the Company shall be under no obligation to issue the Shares covered by such exercise unless the Company has determined that such exercise and issuance would be exempt from the registration requirements of the
1933 Act and until the following conditions have been fulfilled: 
 (a) The person(s) who exercise the Option shall warrant to
the Company, at the time of such exercise, that such person(s) are acquiring such Shares for their own respective accounts, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event
the person(s) acquiring such Shares shall be bound by the provisions of the following legend which shall be endorsed upon any certificate(s) evidencing the Shares issued pursuant to such exercise: 

“The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any
person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel
satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws;” and 

(b) If the Company so requires, the Company shall have received an opinion of its counsel that the Shares may be issued upon such
particular exercise in compliance with the 1933 Act without registration thereunder. Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the
Company deems necessary under any applicable law (including without limitation state securities or “blue sky” laws). 

  
 7 

 12. RESTRICTIONS ON TRANSFER OF SHARES. 

12.1 The Participant agrees that in the event the Company proposes to offer for sale to the public any of its equity securities and such
Participant is requested by the Company and any underwriter engaged by the Company in connection with such offering to sign an agreement restricting the sale or other transfer of Shares, then it will promptly sign such agreement and will not
transfer, whether in privately negotiated transactions or to the public in open market transactions or otherwise, any Shares or other securities of the Company held by him or her during such period as is determined by the Company and the
underwriters, not to exceed 180 days following the closing of the offering, plus such additional period of time as may be required to comply with Marketplace Rule 2711 of the National Association of Securities Dealers, Inc. or similar rules thereto
(such period, the “Lock-Up Period”). Such agreement shall be in writing and in form and substance reasonably satisfactory to the Company and such underwriter and pursuant to customary and prevailing terms and conditions. Notwithstanding
whether the Participant has signed such an agreement, the Company may impose stop-transfer instructions with respect to the Shares or other securities of the Company subject to the foregoing restrictions until the end of the Lock-Up Period.

 12.2 The Participant acknowledges and agrees that neither the Company, its shareholders nor its directors and officers, has
any duty or obligation to disclose to the Participant any material information regarding the business of the Company or affecting the value of the Shares before, at the time of, or following a termination of the service of the Participant by the
Company, including, without limitation, any information concerning plans for the Company to make a public offering of its securities or to be acquired by or merged with or into another firm or entity. 

13. NO OBLIGATION TO MAINTAIN RELATIONSHIP. 
 The Participant acknowledges that: (i) the Company is not by this Option obligated to continue the Participant as an employee, director or consultant of the Company or an Affiliate; (ii) this
Agreement is discretionary in nature and may be suspended or terminated by the Company at any time; (iii) the grant of the Option is a one-time benefit which does not create any contractual or other right to receive future grants of options, or
benefits in lieu of options; (iv) all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the number of shares subject to each option, the option exercise price, and the
time or times when each option shall be exercisable, will be at the sole discretion of the Company; (v) the Participant’s participation in this Agreement is voluntary; (vi) the value of the Option is an extraordinary item of
compensation which is outside the scope of the Participant’s employment contract, if any; and (vii) the Option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of
service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 

  
 8 

 14. DEFINITIONS. 

The following terms, as used in this Agreement, have the following meanings: 

“Administrator” means the Board of Directors of the Company, unless it has delegated power to act on its behalf to the
Committee, in which case the Administrator means the Committee. 
 “Affiliate” means a corporation which, for purposes
of Section 424 of the Code, is a parent or subsidiary of the Company, direct or indirect. 
 “Board of Directors”
means the Board of Directors of the Company. 
 “Cause” means (a) dishonesty with respect to the Company or any
Affiliate, (b) insubordination, substantial malfeasance or non-feasance of duty, (c) unauthorized disclosure of confidential information, (d) breach by the Participant of any provision of any employment, consulting, advisory,
nondisclosure, non-competition or similar agreement between the Participant and the Company or any Affiliate, and (e) conduct substantially prejudicial to the business of the Company or any Affiliate; provided, however, that any provision in an
agreement between the Participant and the Company or an Affiliate, which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede this definition. The determination of the
Administrator as to the existence of Cause will be conclusive on the Participant and the Company. 
 “Change of
Control” means: 
 (i) Ownership. Any “Person” (as such term is used in Sections 13(d) and 14(d) of the
Exchange Act) becomes the “Beneficial Owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then
outstanding voting securities (excluding for this purpose any such voting securities held by the Company or its Affiliates or by any employee benefit plan of the Company) pursuant to a transaction or a series of related transactions which the Board
of Directors does not approve; or 
 (ii) Merger/Sale of Assets. (A) A merger or consolidation of the Company
whether or not approved by the Board of Directors, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity or the parent of such corporation) more than 50% of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation, as
the case may be, outstanding immediately after such merger or consolidation; or (B) the sale or disposition by the Company of all or substantially all of the Company’s assets in a transaction requiring stockholder approval. 

“Code” means the United States Internal Revenue Code of 1986, as amended including any successor statute, regulation and
guidance thereto. 
 “Committee” means the committee of the Board of Directors to which the Board of Directors has
delegated power to act. 

  
 9 

 “Common Stock” means shares of the Company’s common stock, $0.001 par value
per share. 
 “Disability” or “Disabled” means permanent and total disability as defined in
Section 22(e)(3) of the Code. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 “Survivor” means the deceased Participant’s legal representatives and/or any person or persons who acquired
the Participant’s rights to the Option by will or by the laws of descent and distribution. 
 15. NOTICES.

 Any notices required or permitted by the terms of this Agreement shall be given by recognized courier service, facsimile,
registered or certified mail, return receipt requested, addressed as follows: 
 If to the Company: 

BG Medicine, Inc. 
 610 Lincoln Street North 
 Waltham, Massachusetts 02451 

Attention: Chairman of the Board of Directors 
 If to the Participant: 
  

									
		 	  
	  		  		  	
		 	  
	  		  		  	
		 	  
	  		  		  	

 or to such other address or addresses of which notice in the same manner has previously been given. Any such notice shall
be deemed to have been given upon the earlier of receipt, one business day following delivery to a recognized courier service or three business days following mailing by registered or certified mail. 

16. GOVERNING LAW. 
 This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of law principles thereof. For the purpose of litigating any
dispute that arises under this Agreement, the parties hereby consent to exclusive jurisdiction in the Commonwealth of Massachusetts and agree that such litigation shall be conducted in the state courts of Middlesex County, Massachusetts or the
federal courts of the United States for the District of Massachusetts. 

  
 10 

 17. BENEFIT OF AGREEMENT. 

Subject to the other provisions hereof, this Agreement shall be for the benefit of and shall be binding upon the heirs, executors,
administrators, successors and assigns of the parties hereto. 
 18. MODIFICATIONS AND AMENDMENTS. 

The terms and provisions of this Agreement may be modified or amended by the Company in a manner which is not adverse to the Participant.
Any modification or amendment of this Agreement which adversely affects the Participant’s rights under the Option shall not be made without the consent of the Participant. 

19. ENTIRE AGREEMENT. 
 This Agreement embodies the entire agreement and understanding between the parties hereto with respect to the Option and supersedes all prior oral or written agreements and understandings relating
thereto. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict, the express terms and provisions of this Agreement. 

20. WAIVERS AND CONSENTS. 
 The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or
provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the
specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent. 
 21.
DATA PRIVACY. 
 By entering into this Agreement, the Participant: (i) authorizes the Company and each Affiliate,
and any agent of the Company or any Affiliate administering this Agreement or providing recordkeeping services, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order
to facilitate the grant of options and the administration of this Agreement; (ii) waives any data privacy rights he or she may have with respect to such information; and (iii) authorizes the Company and each Affiliate to store and transmit
such information in electronic form. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 11 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer, and the Participant has hereunto set his or her hand, all as of the day and year first above written. 
  

			
	BG MEDICINE, INC.
		
	By:	 	 /s/ Michael W. Rogers

		 	Michael W. Rogers
		 	Executive Vice President & Chief Financial Officer
	
	PARTICIPANT
		
	By:	 	 /s/ Eric Bouvier

		 	Eric Bouvier

 Exhibit A 

NOTICE OF EXERCISE OF STOCK OPTION 
 [Form for Shares registered in the United States] 
  

	To:	BG Medicine, Inc. 

 IMPORTANT NOTICE: This form
of Notice of Exercise may only be used at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance of the Shares for which this exercise is being made is registered and such
Registration Statement remains effective. 
 Ladies and Gentlemen: 
 I hereby exercise my nonqualified-stock option to purchase              shares (the “Shares”) of the common stock, $0.001 par value,
of BG Medicine, Inc. (the “Company”), at the exercise price of $             per share, pursuant to and subject to the terms of that Non-Qualified Stock Option Agreement dated
January 9, 2012 by and between the Company and the undersigned. 
 I understand the nature of the investment I am making
and the financial risks thereof. I am aware that it is my responsibility to have consulted with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option and the
purchase and subsequent sale of the Shares. 
 I am paying the option exercise price for the Shares as follows: 

 
  

 
 Please issue
the Shares (check one): 
  ̈ to me; or 

 ̈ to me and
                                        , as
joint tenants with right of survivorship, 
 at the following address: 

 

			
	  
	  	
	  
	  	
	  
	  	

  
 Exhibit A-1

 My mailing address for shareholder communications, if different from the address listed
above, is: 
  

			
	  
	  	 
	  
	  	 
	  
	  	 

  

	
	Very truly yours,
	
	  

	 Participant (signature)

	
	  

	 Print Name

	
	  
 Date

	
	  
 Social Security Number

  
 Exhibit A-2Non-Employee Director Compensation Policy

 Exhibit 10.36 
 BG MEDICINE, INC. 
 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

 The Board of Directors of BG Medicine, Inc. (the “Company”) has approved the following Non-Employee
Director Compensation Policy (this “Policy”) which establishes compensation to be paid to non-employee directors of the Company, effective as of the closing of the Company’s initial public offering of common stock (the
“Effective Time”), to provide an inducement to obtain and retain the services of qualified persons to serve as members of the Company’s Board of Directors. 
 Applicable Persons 
 This Policy shall apply to each director of the Company
who is not an employee of, or compensated consultant to, the Company or any Affiliate (each, an “Outside Director”). “Affiliate” shall mean a corporation which is a direct or indirect parent or subsidiary of the Company,
as determined pursuant to Section 424 of the Internal Revenue Code of 1986, as amended. 
 Stock Option Grants 

All stock option amounts set forth herein shall be subject to automatic adjustment in the event of any stock split or other
recapitalization affecting the Company’s common stock. 
 Annual Stock Option Grants 

Each Outside Director shall be granted a non-qualified stock option to purchase 4,205 shares of the Company’s common stock under the
Company’s 2010 Employee, Director and Consultant Equity Incentive Plan (the “Stock Plan”) each year at the annual meeting of the Board of Directors following the Company’s annual meeting of stockholders; provided
that if there has been no annual meeting of stockholders held by the first day of the third fiscal quarter of the year in which the Effective Time occurs, each Outside Director will still receive any annual grants of non-qualified stock options
provided for under this Policy on the first day of the third fiscal quarter of such year; and provided further, that if an annual meeting of stockholders is subsequently held during the year in which the Effective Time occurs, no additional
annual grant shall be made. 
 Initial Stock Option Grant For Newly Appointed or Elected Directors 

Each new Outside Director shall be granted a non-qualified stock option to purchase 8,410 shares of the Company’s common stock under
the Stock Plan on the date of his or her initial appointment or election to the Board of Directors. 

 Terms for All Option Grants 

Unless otherwise specified by the Board of Directors or the Compensation Committee at the time of grant, all options granted under this
Policy shall (i) vest one year from the date of the grant, subject to the Outside Director’s continued service on the Board of Directors; provided that such options shall become exercisable in full immediately prior to a change in control
of the Company; (ii) have an exercise price equal to the fair market value of the Company’s common stock as determined in the Stock Plan on the date of grant; and (iii) contain such other terms and conditions as the Board of Directors
or the Compensation Committee shall determine. 
 Cash Fees 
 Annual Cash Payments 
 The following annual cash fees shall be paid to the
Outside Directors serving on the Board of Directors and the Audit Committee, Compensation Committee and Nominating and Governance Committee, as applicable. 
  

									
	 Board of Directors or Committee of Board of Directors
	  	Annual Retainer Amount
for Chair	 	  	Annual Retainer Amount
for Member	 
	 Board of Directors
	  	$	40,000	  	  	$	20,000	  
	 Attendance of at least six (6) Board Meetings per year
	  	$	10,000	  	  	$	10,000	  
	 Audit Committee
	  	$	10,000	  	  	$	3,000	  
	 Compensation Committee
	  	$	5,000	  	  	$	3,000	  
	 Nominating and Governance Committee
	  	$	5,000	  	  	$	3,000	  

 Payment Terms for All Cash Fees 

Cash payments payable to Outside Directors shall be paid quarterly in arrears as of the last day of each fiscal quarter. For any portion
of a fiscal year in which the Effective Time occurs, annual payments shall be pro rated beginning on the first day of the fiscal quarter in which the Effective Time occurs. 
 Following an Outside Director’s first election or appointment to the Board of Directors, such Outside Director shall receive his or her cash compensation pro rated beginning on the first day of the
fiscal quarter in which he or she was initially appointed or elected. If an Outside Director dies, resigns or is removed during any quarter, he or she shall be entitled to a cash payment on a pro rated basis through his or her last day of service.

 Expenses 

Upon presentation of documentation of such expenses reasonably satisfactory to the Company, each Outside Director shall be reimbursed for
his or her reasonable out-of-pocket business expenses incurred in connection with attending meetings of the Board of Directors and Committees thereof or in connection with other business related to the Board of Directors. 

  
 2 

 Amendments 
 The Compensation Committee or the Board of Directors shall review this Policy from time to time to assess whether any amendments in the type and amount of compensation provided herein should be adjusted
in order to fulfill the objectives of this Policy. 

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]